Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06754722 · ClinicalTrials.gov registry record · NA
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
A NA study of Cancer-related Problem/Condition and Health-Related Quality-of-Life, sponsored by 5 Point App.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06754722: Recruiting NA study of Cancer-related Problem/Condition and Health-Related Quality-of-Life, sponsored by 5 Point App.
NCT06754722 is a NA study of Cancer-related Problem/Condition and Health-Related Quality-of-Life that is actively recruiting participants, run by 5 Point App. The registered enrollment target is 180 participants, above the 96-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (88% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06754722, a NA study of Cancer-related Problem/Condition and Health-Related Quality-of-Life, is actively recruiting participants, sponsored by 5 Point App.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate whether EnergyPoints, a mobile phone health app that guides the participant to do self-acupressure, can decrease fatigue and improve sleep. Acupressure consists of applying physical pressure with fingers or a device to small locations on the body called acupoints. * The investigators will conduct this clinical trial remotely, allowing participants to use the app wherever they are. Participation will involve using the app daily while wearing a fitness tracker (a Fitbit) on the wrist, answering questions on the app and online, as well as completing a questionnaire and participating in an online interview at the end of the study. Participants will be assigned by chance to one of two groups. In both groups, participants will have a 1 week baseline week (Week 0) to get used to the Fitbit. Participants in the Immediate Group will start the 6 week trial of EnergyPoints immediately (Week 1). Participants in the Wait-List Group will be on a wait-list for 6 weeks during which time they will wear the Fitbit and answer online questions daily and weekly. At the end of the waiting period (week 7), these participants will begin the 6 week trial of EnergyPoints. * The risks to participating are minimal. There is a small risk of bruising or getting sore at a point where participants apply pressure. As with any mobile app, there is the possibility that electronic information could be viewed by third parties not involved in the study. The investigators cannot promise any benefits from participating in the study. However, it is possible that using acupressure might improve fatigue or sleep. Participants may use any other approaches to improve fatigue and sleep while in the study. A pilot study will be conducted first with 8 participants and 1 week periods (1 week baseline, 1 week waitlist, and 1 week intervention followed by an End of Study Questionnaire and Exit Interview
Primary Outcome
Patient-Reported Outcome Measurement Information System (PROMIS) Fatigue 7a, a standardized measure of fatigue, yields a T score. A T score is a standardized measure on a 0 to 100 scale. The mean is 50 and SD is 10. Higher results indicate more fatigue.
Conditions Studied
Interventions
- OTHER App to guide self-acupressure
Study Locations (1)
New York
- 5 Point App Inc - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06754722 shows while recruiting
NCT06754722 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (88% higher).
The record links to 4 conditions, with Cancer-related Problem/Condition appearing as the primary indexed condition, and to 1 intervention - of which App to guide self-acupressure is the first listed.
NCT06754722 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06754722 about?
NCT06754722 is a clinical study titled "Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors". The purpose of the study is to evaluate whether EnergyPoints, a mobile phone health app that guides the participant to do self-acupressure, can decrease fatigue and improve sleep. Acupressure consists of applying physical pressure with fingers or a device to small locations on the body called acupoi...
What is the current status of trial NCT06754722?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2026-01-15. Estimated completion is 2028-12.
What conditions does trial NCT06754722 study?
This clinical trial studies the following conditions: Cancer-related Problem/Condition, Health-Related Quality-of-Life, Sleep Disturbances, Fatigue in Cancer Survivors.
What interventions are being tested in trial NCT06754722?
The interventions under investigation include: App to guide self-acupressure (OTHER).
Who is sponsoring clinical trial NCT06754722?
This trial is sponsored by 5 Point App, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06754722 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer-related Problem/Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06754722's enrollment target sits among peer trials
180 3rd of 10 higher than 8 of 10 other Cancer-related Problem/Condition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer-related Problem/Condition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
ACTIVE NOT RECRUITING · NA
-
Virtual Exercise Program to Reduce Cancer Related Fatigue
ACTIVE NOT RECRUITING · NA
-
Systematic Light Exposure for Fatigue in Breast Cancer Patients
COMPLETED · NA
-
Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue
COMPLETED · NA
-
Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
COMPLETED · NA
-
The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI